| Calories | 20 | |
| Total Carbohydrates | 5 g | 1% |
| Sugar | 0 g | † |
| Leucine | 3.5 g | † |
| Isoleucine | 1.75 g | † |
| Valine | 1.75 g | † |
| Beta-Alanine | 3.2 g | † |
| Creatine Monohydrate | 5 g | † |
| L-Glutamine | 5 g | † |
% Daily Values for: Adults and children 4 or more years of age.
Where this label comes from
An original label of the NIH's Dietary Supplement Label Database, entered there on 23 March 2018, shown here as it was entered. The NIH's record
General information
- Product name
- Creablast Sour Apple
- Brand
- NSI Sports
- Barcode (UPC)
- Not printed
- Net contents
- 17.78 Oz(s); 504 Gram(s)
- Market status
- Off market
- DSLD ID
- 173870
Classification
- Supplement form
- Powder
- Product type
- Other Combinations
- Claim types on the label
- Nutrient
- Intended for
- Adult (18 - 50 Years)
Label statements
Directions: Daily
FDA Statement of Identity: Dietary Supplement
Directions: Daily use (standalone product used daily anytime)
Formula: Contains: BCAA 2:1:1 Ratio Leucine, Isoleucine, And Valine Dosage: 7.5g
Formula: Contains: 7g BCAA responsible for activator of mTOR - which induces muscle protein synthesis. 3.2g Beta-Alanine to help buffer acid in muscles thus delaying fatigue and increasing stamina. 5g Creatine to rapidly regenerate ATP leading to increased performance, strength, and muscle. 5g Glutamine to prevent muscle breakdown (catabolism) and increase muscle protein synthesis. Beta Alanine Dosage: 3.2g
Formula: Contains: Creatine Monohydrate Dosage: 5g
Formula: Contains: Glutamine Dosage: 5g
Labels only: each label is shown as printed on the bottle, with no grades, rankings or advice. A label in this database is not an endorsement of the product. Read the label on the bottle you buy: makers change their formulas. Reverse Age Lab is not affiliated with, or endorsed by, the National Institutes of Health or its Office of Dietary Supplements. The original labels come from the NIH’s public-domain data; the labels since are read by us. Search the Dietary Supplement Label Database.